Even public health experts are struggling to make the right decisions on whether to cancel plans in the midst of the coronavirus.
Articles
Medicarried Away? (LIVE)
A look at a universal coverage plan that is very different from the Medicare for All we’ve been hearing about.
In Short Supply
Shortages of basic medical supplies have become a familiar pattern for hospitals around the U.S. What causes them? And how can we prevent them?
Primary Concerns
We look at the polls and talk to voters to break down how and why health care is shaping the 2020 election.
The Price of Innovation
Is it possible to lower drug prices without losing out on breakthrough treatments in the future?
‘Hot Spotters’ on Trial
Improving health and lowering costs for the sickest and most expensive patients in America is a dream harder to realize than many health care leaders had hoped.
The Sidebar: Randomized Controlled Trials (RCT)
Randomized controlled trials (RCTs) are often viewed as the “gold standard” of health care research. How do they work and what are their tradeoffs?
Leap of Faith
As the opioid crisis continues to ravage the country, some states are turning to controversial laws that force people into treatment.
The Good Stuff
Two friends—a doctor and an economist—have spent more than 20 years trying to redesign insurance around one simple but elusive goal: make the good stuff more accessible than the bad stuff.
Feeding the Sick
We know good nutrition is tied to good health. But is there evidence that food should be prescribed and paid for like medicine?
